MIS[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”grid” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern” css=”.vc_custom_1516245235385{padding-top: 20px !important;padding-bottom: 20px !important;background-color: #6b6b6b !important;}” z_index=””][vc_column][vc_custom_heading text=”MISSOURI” font_container=”tag:h1|text_align:left|color:%23ffffff” use_theme_fonts=”yes”][/vc_column][/vc_row][vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”1/6″][/vc_column][vc_column width=”2/3″][vc_row_inner row_type=”row” type=”full_width” text_align=”left” css_animation=””][vc_column_inner][vc_empty_space][vc_single_image image=”2968″ img_size=”medium” alignment=”center” qode_css_animation=””][vc_empty_space][vc_column_text]

State House legislators of the “Show Me State” are tentatively testing the waters of legalized medical cannabis. HB 1554 was passed by a voice vote on April 23rd.  The bill authorizes individuals 18 and over suffering from a terminal illness to legally purchases and use cannabis for medical purposes.  The bill also legalizes the use of medical cannabis for treating the symptoms of cancer, Alzheimer’s, post-traumatic stress disorder and a variety of other conditions.

Under the bill, the Missouri Department of Health and Senior Services would be authorized to issue medical cannabis registration cards to residents 18 and older.  These residents will need to provide a signed statement from a doctor that they meet the bill’s criteria.

Some legislators feel the bill is too restrictive and favor a bill that would make cannabis use legal across the board.  Previous bills designed to placate conservative legislators authorized medical cannabis only for patients dying from terminal cancer in hospice. All of those bills were voted down on the basis that they were too restrictive.

The current bill has passed the House and now goes on to the state Senate.  If approved by the Senate, rules and regulations will need to be codified and promulgated.  This is bad news for patients seeking legal medical cannabis therapies.

The fate of the bill in the Senate remains unclear. Opponents say cannabis is still illegal under federal law. The Missouri Association of Prosecuting Attorneys testified against the bill in committee earlier this year.

In Missouri, cannabis legality rests on the flip of a coin.

[/vc_column_text][vc_empty_space height=”15px”][vc_single_image image=”660″ qode_css_animation=””][vc_empty_space height=”15px”][vc_column_text]

A marketing and publishing professional and the Director of Publicity at GB Sciences, Liz Bianco monitors media activity and co-writes the “State of the States” on cannabis in America.


 

[/vc_column_text][vc_single_image image=”1914″ qode_css_animation=””][vc_empty_space height=”15px”][vc_column_text]

A consultant and co-author with Meredith Patterson of “Pillars of Brain Health” at BrainstormMindFitness.com, Pete Goodwin does research and co-writes the State of the States blog.


 

[/vc_column_text][vc_empty_space height=”15px”][/vc_column_inner][/vc_row_inner][vc_column_text]

DISCLAIMER REGARDING SITE CONTENT AND RELATED MATERIALS

Please read these terms and con­di­tions fully and care­fully. If you do not agree to be bound to each and every term and con­di­tion set forth herein, please exit the Site and do not access, read or oth­er­wise use infor­ma­tion pro­vided herein.

The blog pro­vides only gen­eral infor­ma­tion and dis­cus­sion about med­i­cine, health and related sub­jects. Any views or opinions represented in this blog are personal and belong solely to the specific author and do not represent those of people, academic, hospital, practice or other institutions or organizations that the author may or may not be associated with in professional or personal capacity, and do not represent the views or opinions of GB Sciences, Inc., unless explicitly stated.

The words and other con­tent pro­vided in this blog, and in any linked mate­ri­als, are not intended and should not be con­strued as med­ical advice. Noth­ing con­tained in the Site is intended to estab­lish a physician-patient rela­tion­ship, to replace the ser­vices of a trained physi­cian or health care pro­fes­sional, or oth­er­wise to be a sub­sti­tute for pro­fes­sional med­ical advice, diag­no­sis, or treatment. If the reader or any other per­son has a med­ical con­cern, he or she should con­sult with an appropriately-licensed physi­cian or other health care worker. The information is provided by the specific author and the author makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the information, products, services, or related graphics contained in the blog for any purpose. Any reliance placed on such information is therefore strictly at the reader’s own risk.

This blog may contain statements that could be construed to relate to future results or events. Words such as “expects”, “intends”, “plans”, “may”, “could”, “should”, “anticipates”, “likely”, “believes” and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the specific author’s belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the specific author’s control. The specific author’s beliefs are not the beliefs of GB Sciences, Inc., and do not represent the views or opinions of GB Sciences, Inc., unless explicitly stated.

It is possible that the actual results and financial condition of GB Sciences, Inc., may differ, possibly materially, from the anticipated results and financial conditions suggested in these forward-looking statements by the blog author. Information concerning the GB Sciences, Inc., and its business, including factors that potentially could materially affect GB Sciences, Inc., are contained in the company’s filings with the Securities and Exchange Commission, available at www.sec.gov.  Any forward-looking statements included in this blog are made only as of the date of this blog, and neither the specific blog author nor GB Sciences, Inc., undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which they may hereafter become aware.

Through this website and blog you are able to link to other websites that are not under the control of the blog author or GB Sciences, Inc. The blog author and GB Sciences, Inc., have no control over the nature, content and availability of those sites. The inclusion of any links does not imply a recommendation or endorsement of the views and opinions expressed within them.

Con­tent made avail­able at the Site is pro­vided on an “as is” and “as avail­able” basis with­out war­ranties of any kind, either express or implied. Under no cir­cum­stances, as a result of your use of the Site, will the specific author or GB Sciences, Inc., be liable to you or to any other per­son for any direct, indi­rect, inci­den­tal, con­se­quen­tial, spe­cial, exem­plary or other dam­ages under any legal the­ory, includ­ing, with­out lim­i­ta­tion, tort, con­tract, strict lia­bil­ity or oth­er­wise, even if advised of the pos­si­bil­ity of such damages.

By access­ing the Site and/or read­ing its con­tent, you acknowl­edge and agree that you have read and under­stand these terms and con­di­tions, that the pro­vi­sions, dis­clo­sures and dis­claimers set forth herein are fair and rea­son­able, and that your agree­ment to fol­low and be bound by these terms and con­di­tions is vol­un­tary and is not the result of fraud, duress or undue influ­ence exer­cised upon you by any per­son or entity.

[/vc_column_text][vc_empty_space][/vc_column][vc_column width=”1/6″][/vc_column][/vc_row]

[social_share_list]